Ocular Therapeutix (OCUL) Interest Expenses (2013 - 2026)

Ocular Therapeutix's Interest Expenses history runs 14 years deep, the most recent figure standing at $2.8 million for Q1 2026.

• In Q1 2026, Interest Expenses fell 6.94% year-over-year to $2.8 million; the TTM figure through Mar 2026 stood at $11.6 million (down 7.06% YoY), while the FY2025 annual figure was $11.8 million, down 12.83% from the prior year.
• Interest Expenses was $2.8 million for Q1 2026 at Ocular Therapeutix, down from $2.8 million in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $4.2 million in Q4 2023 to a low of $1.7 million in Q1 2022.
• Historically, Interest Expenses has averaged $2.7 million across 5 years, with a median of $3.0 million in 2025.
• The sharpest annual moves came in 2024 and 2025: Interest Expenses soared 129.13% in 2024, then fell 26.34% in 2025.
• A 5-year view of Interest Expenses shows it stood at $1.8 million in 2022, then soared by 124.74% to $4.2 million in 2023, then dropped by 25.17% to $3.1 million in 2024, then dropped by 8.82% to $2.8 million in 2025, then dropped by 1.94% to $2.8 million in 2026.
• The last three Interest Expenses figures came in at $2.8 million (Q1 2026), $2.8 million (Q4 2025), and $3.0 million (Q3 2025), per Business Quant data.